ESLICARBAZEPINE ACETATE

SynDRA canonical compound SYN0003522 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CYP2C19 \| CYP3A4 \| SCN10A \| SCN11A \| SCN1A \| SCN2A \| SCN3A \| SCN4A \| SCN5A \| SCN7A \| SCN8A \| SCN9A
Mechanism of action	sodium channel blocker
Indication	seizures
Disease area	neurology/psychiatry

All known targets

SCN10A
SCN11A
SCN1A
SCN2A
SCN3A
SCN4A
SCN5A
SCN7A
SCN8A
SCN9A
CYP2C19
CYP3A4

Mechanisms of action (all sources)

SCN1A BLOCKER
Sodium channel alpha subunit blocker
SCN5A BLOCKER
SCN4A BLOCKER
SCN7A BLOCKER
SCN2A BLOCKER
SCN9A BLOCKER
SCN3A BLOCKER
SCN11A BLOCKER
SCN8A BLOCKER
SCN10A BLOCKER
sodium channel blocker

Drug classes

Anticonvulsants
Cardiovascular Agents
Central Nervous System Agents
Membrane Transport Modulators
Sodium Channel Blockers
Voltage-Gated Sodium Channel Blockers
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers

ATC classes

ANTIEPILEPTICS

Cross-references

PubChem CID: 179344
ChEMBL: CHEMBL87992
DrugBank: DB09119
ChEBI: 87016
KEGG: D09215
RxNorm: 1482501
Wikipedia: Eslicarbazepine_acetate

Synonyms

Look up ESLICARBAZEPINE ACETATE in the interactive SynDRA portal →